# Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care Treatment

> **NCT01421862** · — · UNKNOWN · sponsor: **National Cancer Institute (NCI)** · enrollment: 400 (estimated)

## Conditions studied

- Leukemia

## Interventions

- **GENETIC:** DNA methylation analysis
- **GENETIC:** RNA analysis
- **GENETIC:** gene expression analysis
- **GENETIC:** microarray analysis
- **GENETIC:** mutation analysis
- **GENETIC:** nucleic acid sequencing
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01421862
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2011-10
- **Final completion:** —
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2013-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01421862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01421862, "Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care Treatment". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01421862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*